AbbVie (ABBV) has submitted an application to the US FDA seeking approval for SKYRIZI for subcutaneous (SC) induction for the treatment of adult patients with moderately to severely active Crohn's disease

AbbVie's application to the US FDA for SKYRIZI signals a strategic move to expand its treatment portfolio, particularly for Crohn's disease.

Newsquawk StaffPublished 27 Apr 2026, 12:30 UTCOn the live feed at 12:10 UTC — 4 more headlines followed before this page went public

Newsquawk headlinesUTC

12:25

Walmart (WMT) files to sell a 5-part note offering

12:24

Intel (INTC) files to sell USD-denominated notes in 5-part offering

12:10

AbbVie (ABBV) has submitted an application to the US FDA seeking approval for SKYRIZI for subcutaneous (SC) induction for the treatment of adult patients with moderately to severely active Crohn's disease

12:09

A Hezbollah military leader told Al Jazeera: We will use the tactics of the 1980s and activate suicide squads to prevent the enemy from establishing stability.

12:09

Critical Metals (CRML) to acquire European Lithium for USD 835mln

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Try the platform free

Free. No signup, no card.

Submission supported by data from Phase 3 pivotal AFFIRM study

Context

The backing from the Phase 3 AFFIRM study adds weight to the application, suggesting that if approved, it could bolster AbbVie's market position and revenue growth in the gastrointestinal treatment space. Investors should monitor potential implications for sales forecasts and the competitive landscape in the biotechnology sector.

Equities · last 90 days

Recent headlines that moved markets

EQUITIES/8 Sept · 05:24 UTC

Saudi Energy Minister says a number of energy facilities and utilities were hit; are temporarily halting some operations.

Equity indices, after we published−0.3%

Modest downside seen across equity futures as energy prices tick higher.

EQUITIES/3 Sept · 04:54 UTC

North Korea stripped references to "peaceful unification" with South Korea from the charter of its ruling Workers' Party of Korea, according to Yonhap.

Equity indices, after we published−3.3%

EQUITIES/1 Sept · 16:17 UTC

Initial reports of an American attack on Iran, reports i24's Stein.

ES, after we published−0.2%

EQUITIES/26 Aug · 12:56 UTC

States and Meta (META) and agree to settle claims that platforms harmed children, according to a court filing; Meta agrees to pay a maximum of USD 16.68bln to states as part of deal

Market, after we published+2.6%

EQUITIES/7 Sept · 10:54 UTC

Saudi Aramco Jizan oil facilities were reportedly hit in new strikes, the FT reports citing sources; hit on Monday, damage is being assessed.

Equity indices, after we published−0.1%

EQUITIES/7 Sept · 09:15 UTC

Volkswagen (VOW3 GY) says that the Co., Lower Saxony and Aurelius Capital have agreed on key terms for the sale of Osnabrueck Plant; aims to secure the site and majority of jobs in the long term.

Market, after we published+1.6%

Newsquawk Daily

Get both market opens in your inbox.

This note and the other one — the EU open and the US open, every business day, written by the desk. No account needed.

Related headlines

The whole workspace, free to try.

© 2026 Newsquawk. All rights reserved.